Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

Sanie SesaySanofi Pasteur, Marcy l'Etoile, France

Jerzy BrzostekClinic of Infectious Diseases Health Care Team, Dębica, Poland

Ingo MeyerCRS Clinical Research Services Kiel GmbH, Lübeck, Germany

Yves DonazzoloEurofins-Optimed, Gières, France

Geert Leroux-RoelsCenter for Vaccinology, Ghent University and University Hospital, Gent, Belgium

Régine RouzierCentre CAP, Centre Médical Odysseum, Montpellier, France

Béatrice AstrucBiotrial, Rennes Cedex, France

Henryk SzymanskiSt Hedwig of Silesia Hospital, Department of Paediatrics, Prusicka, Trzebnica, Poland

Nicole ToursarkissianMedic Trials, Berlin, Germany

Corinne VandermeulenLeuven University Vaccinology Center, Leuven, Belgium

Edyta Kowalska“Medyk”, Wola, Poland

Pierre Van DammeCentre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, Antwerpen (Wilrijk), Belgium

Camille SalamandSanofi Pasteur, Marcy l'Etoile, France

Stephanie PepinSanofi Pasteur, Marcy l'Etoile, FranceCorrespondence[email protected]

Your download is now in progress and you may close this window